NanoVibronix, Inc. (NAOV) News
Filter NAOV News Items
NAOV News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NAOV News Highlights
- For NAOV, its 30 day story count is now at 4.
- Over the past 7 days, the trend for NAOV's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- WAVE are the most mentioned tickers in articles about NAOV.
Latest NAOV News From Around the Web
Below are the latest news stories about NANOVIBRONIX INC that investors may wish to consider to help them evaluate NAOV as an investment opportunity.
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingELMSFORD, N.Y., September 06, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that Dr. Sandra Wilks is scheduled to present the findings from her study of UroShield® at the International Continence Society (ICS) 2023 Conference in Toronto on Wednesday, September 27. |
Dear ACHR Stock Fans, Mark Your Calendars for Sept. 12Archer Aviation (ACHR) stock fans will want to keep an eye on the urban air mobility company when Sept. 12, 2023, rolls around! |
Why Is NanoVibronix (NAOV) Up 153% Today?NanoVibronix (NAOV) stock is climbing higher on Wednesday after releasing independent results from a study of its UroShield medical device. |
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq RulesELMSFORD, N.Y., August 30, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,906,977 shares of its common stock (or common stock equivalents in lieu thereof), series A-1 warrants to purchase up to 2,906,977 shares of common stock and series A-2 |
Why Is NanoVibronix Stock Trading Higher Today?NanoVibronix Inc (NASDAQ: NAOV) reported outcomes from a UroShield study conducted at the University of Southampton in the U.K. Quantitative data from the research indicated a positive effect of UroShield on catheter-associated urinary tract infections (CAUTI) and catheter blockage, with approximately one-third of patients in the study citing a reduction in the frequency of catheter blockages and the need for unscheduled catheter challenges. Furthermore, qualitative data indicated favorable opin |
NanoVibronix Cites Positive Results from Independent Testing of UroShieldELMSFORD, N.Y., August 30, 2023--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today cited positive reported outcomes from a study of UroShield® that was conducted at the University of Southampton in the United Kingdom. |
NanoVibronix Responds to CMS’ Determination for PainShieldELMSFORD, N.Y., August 29, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today provided a response to the recently published payment determination by the Centers for Medicare & Medicaid Services ("CMS") regarding the company’s PainShield device. |
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffELMSFORD, N.Y., August 28, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today provided an update on its efforts to expand distribution of its UroShield family of products. |
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield PlusELMSFORD, N.Y., August 23, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has conditionally extended its distribution agreement with Ultra Pain Products, Inc. ("UPPI") for the company’s PainShield® and PainShield Plus®. |
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-GuardELMSFORD, N.Y., June 14, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a distribution agreement with Mio-Guard, LLC ("Mio-Guard") for the sale and distribution of its PainShield MD product. |